BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immuno-oncology cancer therapies. They aim to improve patient outcomes by addressing treatment resistance and tackling development gaps in the cancer drug market. With a strong pipeline of promising drug candidates, BeyondSpring is poised to make a significant impact in the fight against cancer.
Notification